RxDoctor Payments Data

Amanda Murray, NP

Family · Great Falls, MTNPI 1033727185

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Urgo Medical North America, LLC accounts for 73.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $58,418 and has fallen 73.8% since, to $15,322 in 2025. Among family clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$100,932in general payments, 2019–2025

Across 168 payments — averaging $600.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Urgo Medical North America, LLC$74K
  • Imbed Biosciences Inc.$24K
  • Solventum Corporation$2K
  • Smith+Nephew$535
  • Organogenesis Inc.$367
  • Next Science LLC$90
  • plus $248 from 7 others

What the payments were for

  • Consulting fees$16,20016%
  • Speaking & faculty fees$48,86748%
  • Travel & lodging$31,70431%
  • Food & beverage$4,1604%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$100,932 in reported general payments places this provider in the 95th percentile of 481 family providers in Montana.

See all family providers in Montana

Medicare billing

Part B allowed, 2024
$19,003
Medicare patients
101
Services billed
430

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate37$494
Triamcinolone Acetonide13$187

Paid to pharmacies, not to this prescriber.

Other family in Great Falls

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →